Personalized cell therapy for cancer using tumour-trained lymphocytes
| Date | Round | Amount |
|---|---|---|
| Mar 2024 | Grant Stockholm biotech NEOGAP Therapeutics received a ~EUR 500K Eurostars grant for a project with Okomera to advance its personalized cancer immunotherapy. | $540K |
| Nov 2023 | Funding round Stockholm biotech Neogap Therapeutics raised 7.1M EUR (share issue plus EU innovation grant) to fund its Phase I/II personalized cancer cell-therapy study. | $7.7M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.